Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Powerbox announces industry’s first power supply for immerged computing applications

Powerbox, one of Europe’s largest power supply companies, and for more than four decades a leading force in optimizing power solutions for demanding applications, has announced the release of its ‘industry first’ power supply solution for immerged applications such as hyper loaded computing machines. The OFI600A12 is the first commercial power supply designed to meet immerged applications specifications and guarantee the highest level of safety for system and operators. With its built-in digital supervising functions, in just a few minutes the OFI600A12 can be factory reconfigured to meet

Otello Corporation announces third quarter results

Oslo, Norway - November 13, 2019 - Otello Corporation today reported financial results for the third quarter, which ended September 30, 2019. Please find the third quarter report (3Q19.pdf) and third quarter presentation (3Q19_presentation.pdf) attached. Webcast: https://www.otellocorp.com/ir Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com About Otello: Otello holds shares in several different businesses, including (i) AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for

Sedana Medical AB (publ), Interim report Q3, 2019

Strong sales growth and good progress towards registrationFinancial summary, July - September · Net sales during the third quarter amounted to KSEK 16,416 (12,682) corresponding to an increase of 29% compared with the same period in 2018. · Earnings before interest, taxes, depreciation and amorti­sation (EBITDA) amounted to KSEK -4,029 (-964) KSEK. This corresponds to an EBITDA margin of -25% (-8%). · Earnings before interest and taxes (EBIT) amounted to KSEK -5,093 (-2,051), which corresponds to an EBIT margin of -31% (-16%). · Cash flow from operations before changes in

Record quarter and strong pipeline

Oslo, Norway (13 November 2019) NattoPharma increased revenues by 31% in the third quarter and 25% for the first nine months of 2019. Adjusted EBITDA in the quarter came in at NOK 3,2 million. (mnok) Q3’19 Q3’18 YTD’19 YTD’18Product Revenue 30,9 23,6 88,6  70,8Gross Margin 43,0% 45,5% 42,0% 42,9%EBITDA (adj.) 3,2 1,1 6,0 3,6 CEO, Kjetil Ramsøy: “We are very pleased with this quarter. It shows the scalability of our business model as we can sell more product without adding additional overhead cost. The underlying revenue growth

Insr: Q3 2019 results: Consolidating Norway

Oslo, November 13th, 2019   Insr Insurance Group ASA (OSE:INSR) announces results for third quarter of 2019. A presentation of the results by the Group’s senior management will take place today at 08:30 CET - see details below. The result in the third quarter, a loss of NOK 12.5 million, is significantly impacted by non-recurring effects. The continuing business in the Norwegian home market reports a net result of NOK 7.8 million, while primarily non-recurring items give a net loss for discontinued operations of NOK 20.3 million. The ongoing business in the Norwegian market

Nordic Nanovector ASA: Invitation to Third Quarter 2019 Results Presentation and Webcast

Oslo, Norway, 13 November 2019   Nordic Nanovector ASA (OSE: NANO) announces that it will report its results for the third quarter 2019 on Tuesday, 19 November 2019. A presentation by Nordic Nanovector’s senior management team will take place at 8:30am CET at: Thon Hotel Vika Atrium, Munkedamsveien 45, 0250 Oslo Meeting Room: AKER The presentation will be recorded as a webcast and will be available at www.nordicnanovector.com in the section: Investors & Media The results report and the presentation will be available at www.nordicnanovector.com in the section: Investors &

Selvaag Bolig ASA: record result and high level of activity

Selvaag Bolig had an EBITDA (IFRS) adjusted for financial expenses of NOK 254 million for the third quarter of 2019. This was up by NOK 169 million from the same period of last year and is the best third-quarter result in the company’s history. Ongoing value creation in Selvaag Bolig is revealed by the operating margin, based on progress and sales in current projects. The third quarter was characterised by good sales and production, and the operating profit (EBITDA) according to NGAAP came to NOK 172 million (2018: NOK 155 million). That corresponds to an EBITDA margin of 26.5 per

Light at the end of the nanotunnel for future catalysts

Using a new type of nanoreactor, researchers at Chalmers University of Technology, Sweden, have succeeded in mapping catalytic reactions on individual metallic nanoparticles. Their work could help improve chemical processes, and lead to better catalysts and more environmentally friendly chemical technology. The results are published in the journal Nature Communications.  Catalysts increase the rate of chemical reactions. They play a vital role in many important industrial processes, from making fuels to medicines, to helping limit harmful vehicle emissions. They are also essential

VTT’s deep-tech incubator teams come up with two solutions to meet the need for new sustainable fish feed

Food shortages are a major global issue. Population growth is increasing the need for food, and growing wealth is driving demand for animal protein foods. VTT’s deep-tech incubator LaunchPad promotes the commercialisation of solutions relating to, for example, animal feed and especially fish farming.VTT LaunchPad includes two ventures that are looking for answers to the problems of fish feed production: Enifer Bio and Volare. Enifer Bio’s solution is based on the use of dilute side streams from the agro- and forest industries, and Volare’s solution focuses on the valorisation of food-

Sedana Medical’s board member Michael Ryan resigns

Sedana Medical AB (publ) (SEDANA: FN Stockholm) today announced that Michael Ryan is retiring and therefore is resigning from the company’s board of directors.“I have now decided to retire and move to Portugal. As a result, I have decided it is a good time for me to leave the board. I have greatly enjoyed the many years I have spent as an executive and on the board and I am confident that Sedana Medical has never been in a better position to bring inhaled sedation to a global standard of care therapy. In connection with the new share issue earlier in October I actually bought an additional

SDLP – Notice of 2019 Annual Meeting of Members

London, United Kingdom, November 12, 2019 - Seadrill Partners LLC announces today that it has scheduled its 2019 Annual Meeting. Notice is hereby given that the Annual Meeting of Members will be held on December 19, 2019. Holders of common units at the close of business on November 22, 2019 will be entitled to vote at the meeting. The notice, agenda and associated material will be available on our website http://www.seadrillpartners.com on November 22, 2019.

Lloyd Perry resigns as a member of Humana's Board of Directors

Lloyd Perry resigns on his own request as a board member of Humana AB.Lloyd Perry has been a member of Humana's Board of Directors since 2008, when Argan Capital Advisors LLP, where Lloyd Perry is a Managing Partner, via Air Syndication SCA became the principal owner of Humana AB. In 2019, Argan Capital has reduced its shareholding and is no longer the largest shareholder of the company. As a consequence of the reduced shareholding, Lloyd Perry has also chosen to resign from the Board of Directors. Lloyd Perry resigns with immediate effect. For more information, please contact:Sören

#19-1129 Adjustment to warrants with Kinnevik Investment AB Ser. B as underlying due to extra distribution

The recalculation will be effective as from November 13, 2019. Please contact the issuer for detailed information about the recalculation.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGM Nordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete

Vicore Pharma intends to carry out a directed share issue

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, THE UNITED KINGDOM, CANADA, HONGKONG, JAPAN, NEW ZEELAND, SINGAPORE, SOUTH AFRICA, THE UNITED STATES OF AMERICA OR ANY OTHER JURISDICTION WHERE THE PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION MEASURES OR ANY OTHER MEASURE UNDER APPLICABLE LAW. THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO, OR INVITATION TO, ACQUIRE OR SUBSCRIBE FOR ANY FINANCIAL INSTRUMENTS IN VICORE PHARMA IN ANY JURISDICTION.. Gothenburg, November 12, 2019 – Vicore Pharma Holding AB (publ) (“

Contemplated sale of shares in Ambea AB (publ)

Press release, November 12, 2019 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA (INCLUDING ITS TERRITORIES AND POSSESSIONS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA, THE “UNITED STATES”), THE UNITED KINGDOM, CANADA, JAPAN, AUSTRALIA, HONG KONG, SWITZERLAND, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD BE UNLAWFUL. Carnegie Investment Bank AB (”Carnegie”) and Nordea Bank Abp, filial i Sverige (“Nordea”) have been retained by Actor SCA (“Actor”) to explore the opportunity

Contemplated sale of shares in Bonesupport Holding AB

12 November 2019 THIS DOCUMENT IS FOR THE USE OF THE INTENDED RECIPIENT ONLY AND SHOULD NOT BE COPIED OR DISTRIBUTED TO ANY OTHER PERSON. NOT FOR DISTRIBUTION IN OR INTO THE U.S. (OR TO U.S.PERSONS) ABSENT REGISTRATION OR AN EXEMPTION FROM REGISTRATION UNDER U.S. SECURITIES ACT OF 1933, AS AMENDED, OR IN ANY OTHER JURISDICTION IF SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF APPLICABLE SECURITIES LAWS.ABG Sundal Collier has been engaged by a shareholder (the ”Seller”) to explore the opportunity to sell

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 12.11.2019

Fiskars Corporation  NOTIFICATION 12.11.2019 at 18:30 EET/EEST FISKARS CORPORATION: ACQUISITION OF OWN SHARES 12.11.2019 Date 12.11.2019Exchange transaction BuyShare class FSKRSAmount       1000Average price/share 11.8900 EUR  Highest price/share 11.9200 EUR Lowest price/share 11.8600 EUR Total price  11,890.00 EUR  The shares held by Fiskars Corporation on 12.11.2019: FSKRS 378,677  On behalf of Fiskars Corporation Skandinaviska Enskilda Banken AB (Publ) Antti Salakka   Mikko

United Bankers Corporation: Acquisition of Own Shares 12.11.2019

United Bankers Corporation NOTIFICATION   12.11.2019 at 18:30   UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 12.11.2019 Date 12.11.2019Exchange transaction BuyShare class UNIAVAmount 300Average price/share 8.5500 EURHighest price/share 8.5500 EURLowest price/share 8.5500 EURTotal price 2,565.00 EUR The shares held by United Bankers Corporation on 12.11.2019: UNIAV 34,520 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ)   Antti

BEWiSynbra announces tender offer regarding outstanding SEK bonds

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

Heimstaden Bostad issues hybrid capital

NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS, ANY STATE OF THE UNITED STATES AND THE DISTRICT OF COLUMBIA) OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT. THE DISTRIBUTION OF THIS DOCUMENT IN CERTAIN JURISDICTIONS (IN PARTICULAR, THE UNITED STATES AND

#19-1128 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

SpareBank 1 SR-Bank: Distribution of shares as part of the savings scheme for employees

The shares purchased by SpareBank 1 SR-Bank ASA 1, 4 and 5 November 2019 for use in the group's savings scheme for employees, have been distributed to the employees at a price of NOK 99,251  After allocation the banks total holding of own shares is 91.130 shares.  As participants in the savings scheme the primary insiders have acquired shares in accordance with the enclosed list.

Cimco Marine AB (publ) receives significant order for the OXE300 with a value of approx. EUR 3 million from one of its distributors in the Americas

Cimco Marine AB (publ) has today received orders for the OXE300 from one of its distributors in the Americas in respect to mainly governmental use. The total revenue for this order is approx. EUR 3 million for the base units, excluding accessories, service kits and spare parts.Delivery of the OXE300 units will commence once start of production commences, which is expected to be in the second quarter of 2020. The entire order is expected to be delivered during 2020. “I am extremely pleased that, following the successful marketing launch of the OXE300 at the Genoa Boat show in September,

There are no items matching the current filter
There are no more items matching the current filter
Back to top